MSB 1.58% 96.5¢ mesoblast limited

MSB to dispute FDA finding in Type A meeting, page-312

  1. 1,216 Posts.
    lightbulb Created with Sketch. 1375
    Well I found this part of the document very interesting.....thoughts?

    V. How Do I Overcome the Deficiencies in my CRL?

    "The FDA is empowered to waive “any criteria of an adequate and well-controlled study” if an adequate substitute is offered or if compliance with the requirement is unnecessary or impossible.25 Some applicants cure deficiencies by presenting colorable arguments that the FDA’s requirements were impractical or unnecessary. The FDA may grant a waiver if it finds the applicant’s compliance with the requirement is not necessary or not achievable, the applicant has satisfied the requirement through an acceptable alternative, or “[t]he applicant’s submission otherwise justifies a waiver.” While the FDA does not dispense waivers lightly, they remain a potential strategy to overcome certain deficiencies."

    Something tells me the FDA did not take this into account when processing the application.


    Last edited by Zenox: 04/10/20
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
96.5¢
Change
0.015(1.58%)
Mkt cap ! $1.090B
Open High Low Value Volume
94.5¢ 97.8¢ 93.5¢ $1.708M 1.779M

Buyers (Bids)

No. Vol. Price($)
20 49771 96.5¢
 

Sellers (Offers)

Price($) Vol. No.
97.0¢ 133258 41
View Market Depth
Last trade - 13.15pm 12/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.